Combating Illicit Xylazine Act

Combating Illicit Xylazine Act – Plain English Summary

This bill focuses on addressing the growing public safety threat posed by xylazine, a powerful sedative drug that is increasingly being mixed with illicit drugs like fentanyl on the street. Xylazine is a veterinary medication — meaning it is legally approved for use in animals, not humans — but it has been appearing more frequently in the illegal drug supply. The bill aims to control and restrict xylazine by placing it under federal drug scheduling laws, making its unauthorized possession and distribution illegal under the Controlled Substances Act.

By scheduling xylazine as a controlled substance, the bill would give law enforcement new legal tools to prosecute those who distribute it illegally. It would also create stricter oversight of how the drug is manufactured, distributed, and handled — similar to the controls already in place for other regulated substances. People who are caught illegally possessing or trafficking xylazine could face federal criminal penalties under this framework.

The bill primarily affects drug traffickers and others who distribute xylazine outside of legal channels, as well as veterinary and medical professionals who work with the drug and would need to comply with new regulations. It could also have indirect effects on communities dealing with the opioid and synthetic drug crisis, since xylazine mixed with fentanyl has been linked to particularly dangerous overdoses and severe skin wounds that are difficult to treat medically.

The bill was introduced in the Senate and has been reviewed by the Senate Judiciary Committee, which approved it with some modifications. It has not yet been passed into law.